-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
According to statistics, in 2018, there were 570,000 new cases of cervical cancer worldwide, and 311,000 people died of cervical cancer.
Dr.
The researchers combined the age-specific incidence of the 2018 Global Vaccine Program with the age-specific cohort-specific mortality predicted by the United Nations population to quantify the absence of HPV vaccines for girls born between 2005 and 2014 Number of expected cases of cervical cancer.
prevention
Global cervical cancer risk for girls born between 2005 and 2014
Global cervical cancer risk for girls born between 2005 and 2014Globally, without vaccination, the burden of cervical cancer in the cohort of this study is expected to reach 116 million cases in 2094 .
Globally, without vaccination, the burden of cervical cancer in this study cohort is expected to reach 116 million cases in 2094.
Global immunization with HPV vaccines against HPV 16 and 18 and cross-protection against HPV 31, 33 and 45 can prevent about 87 million cases of immunization
In short, HPV vaccination can significantly reduce the burden of cervical cancer in the future.
HPV vaccination can significantly reduce the burden of cervical cancer in the future, especially for countries in non-developed regions.
Original source:
Maxime Bonjour, et al.
org/10.
1016/S2468-2667(21)00046-3" target="_blank" rel="noopener">Global estimates of expected and preventable cervical cancers among girls born between 2005 and 2014: a birth cohort analysis in this message